Porokeratosis is an uncommon skin condition that produces small, raised, ring-shaped patches with a distinctive ridged border. The center of each patch often looks thin or slightly flattened compared to the surrounding skin. It is classified as a precancerous condition, meaning the lesions carry a small but real risk of developing into skin cancer over time, which is why ongoing monitoring matters.
What Porokeratosis Looks Like
The lesions typically start as small, callus-like bumps (called keratotic papules) or flat, round-to-oval plaques. Over time, they tend to expand outward from their center. The hallmark feature is a well-defined, raised ridge around the edge, almost like a tiny wall or crater rim. Inside that border, the skin often appears thinner, drier, or slightly sunken compared to normal skin. Lesions can range from a few millimeters to several centimeters across.
Under a microscope, dermatologists look for a structure called the cornoid lamella, a narrow column of abnormal skin cells stacked tightly together in the outermost layer of skin. This feature is unique to porokeratosis and is what confirms the diagnosis when a skin biopsy is taken.
Types of Porokeratosis
There are several recognized variants, and they differ mainly in where lesions appear, how many develop, and what triggers them.
- Disseminated superficial actinic porokeratosis (DSAP) is the most common form. It produces many small lesions, primarily on sun-exposed areas like the arms and legs, though it can appear elsewhere. DSAP tends to worsen in summer and improve in winter. It is strongly linked to UV exposure.
- Porokeratosis of Mibelli is the classic form, usually appearing in childhood or adolescence as a single, slowly expanding plaque, often on a limb.
- Linear porokeratosis follows a line or band pattern along one side of the body, sometimes tracking along a limb. It also tends to appear early in life and carries a higher risk of malignant transformation than other forms.
- Porokeratosis palmaris et plantaris disseminata begins on the palms and soles before spreading to other body areas.
- Punctate porokeratosis produces tiny, seed-like lesions on the palms and soles.
What Causes It
Porokeratosis has a genetic foundation. Researchers have identified mutations in genes that control the mevalonate pathway, a cellular process your body uses to build cholesterol and other essential molecules. The specific genes involved include MVK, MVD, PMVK, and FDPS. In familial cases, a person inherits one faulty copy of one of these genes. The lesions themselves appear when a “second hit,” a second mutation in the remaining healthy copy, occurs in a particular patch of skin cells. That localized double loss of function is what produces the characteristic abnormal skin growth at that spot.
This genetic vulnerability explains why porokeratosis can run in families, but it also appears in people with no family history. Sporadic mutations in the same pathway genes can produce the same result.
Triggers That Bring It On or Make It Worse
Two major environmental factors are closely linked to the onset and flare-up of porokeratosis: ultraviolet light exposure and immune suppression. DSAP in particular often appears or worsens after significant sun exposure, which is why it’s most visible during warmer months.
Immune suppression is the other key trigger. People taking immunosuppressive medications (for example, after an organ transplant or for autoimmune diseases) develop porokeratosis at higher rates. The weakened immune surveillance likely allows the abnormal skin cells to proliferate unchecked. Some case reports have also explored a possible connection to viral infections in immunosuppressed patients.
Conditions It Can Be Confused With
Porokeratosis is uncommon enough that it can be mistaken for more familiar skin conditions. Actinic keratosis (sun damage spots) is one of the most common look-alikes, but the scale pattern differs: actinic keratosis has its rough, scaly texture in the center of the lesion, while porokeratosis concentrates its ridge at the border. Other conditions in the differential include psoriasis (especially the small, scattered “guttate” form), ringworm, lichen planus, granuloma annulare, seborrheic keratosis, flat warts, and superficial basal cell carcinoma. A skin biopsy showing the cornoid lamella is the definitive way to tell them apart.
Cancer Risk
Porokeratosis is considered precancerous. Across all types, the estimated risk of a lesion transforming into squamous cell carcinoma, Bowen disease, or basal cell carcinoma is roughly 7.5%. That risk is not spread evenly across variants. DSAP carries a lower transformation rate, around 3.4%. Linear porokeratosis is substantially more concerning, with transformation rates reported as high as 19%. One Japanese cohort of 198 patients found that 11.6% developed skin cancer within their porokeratosis lesions.
Because of this risk, yearly skin examinations are recommended for anyone with porokeratosis. You should watch for changes within existing lesions, particularly new growths, ulceration, rapid enlargement, or bleeding, as these can signal malignant transformation.
Treatment Options
There is no single cure for porokeratosis, and treatment depends on the type, the number and location of lesions, and the individual’s risk factors. For limited disease, the goal is usually to remove or flatten the lesions and reduce cancer risk. For widespread disease like DSAP with dozens of spots, complete clearance is more challenging.
Topical Treatments
Several prescription creams are used to treat porokeratosis. Fluorouracil (5-FU) cream works by targeting rapidly dividing abnormal skin cells. It is sometimes combined with calcipotriene, a vitamin D derivative, applied twice daily for short treatment cycles. Imiquimod cream, which stimulates the skin’s local immune response, has also shown effectiveness when applied three to five days per week for five to six weeks, sometimes with a covering over the treated area to improve penetration. The combination of imiquimod and 5-FU has been particularly useful for immunosuppressed patients, including organ transplant recipients. Topical retinoids and cholesterol-lowering creams (which target the same mevalonate pathway disrupted by the genetic mutations) are other options.
Procedural Treatments
Cryotherapy (freezing with liquid nitrogen) is a straightforward option for isolated lesions. For more widespread involvement, CO2 laser ablation can vaporize lesions, though it sometimes struggles to fully eliminate the raised border. Photodynamic therapy, which uses a light-sensitizing cream followed by targeted light exposure, has been used alone or after laser treatment. Results vary: some patients see significant clearing after three or four sessions, while others respond less dramatically. The combination of laser ablation followed by photodynamic therapy may work better than either treatment alone, though even combined approaches sometimes leave residual changes like mild discoloration. Surgical removal is reserved for single lesions or when there is concern about malignant transformation in a specific spot.
Oral retinoids, such as acitretin, are sometimes prescribed for widespread disease that does not respond well to topical or procedural approaches. Regardless of treatment choice, recurrence is common, and ongoing sun protection is important for all patients, especially those with DSAP.